Answers are grounded in this paper and cite their sources.
Observational review identifies causes and treatment outcomes of lymphadenitis in cats, indicating effective glucocorticoid therapy.
Objectives: To review diagnoses and infectious disease testing of cats with neutrophilic or pyogranulomatous lymphadenitis, and describe the history, clinicopathological abnormalities, diagnostic imaging findings, lymph node cytological/histological appearance, treatment response and outcome of steroid-responsive lymphadenitis in cats. Methods: Medical records of 72 cats documented to have pyogranulomatous, neutrophilic or mixed lymphadenitis between January 2015 and December 2023 at a single referral hospital were retrospectively reviewed. Results: Feline infectious peritonitis (FIP) (25/72, 35%) was the most common cause of lymphadenitis and frequently pyogranulomatous. Neoplasia (11/72, 15%) was the overall next most common cause and the most common cause of neutrophilic lymphadenitis. The remaining diagnoses included nine cats (12.5%) with steroid-responsive lymphadenitis, eight (11%) inflammatory disease, seven (10%) other suspected bacterial infections, five (7%) mycobacterial infections, five (7%) neutrophilic to pyogranulomatous lymphadenitis of unclear cause and two (3%) toxoplasmosis with variable inflammatory lymphadenitis. Steroid-responsive lymphadenitis cases were often middle-aged (median 7 years 10 months) neutered males (6/9). Common signs included lethargy (7/9, 78%), hyporexia/anorexia (7/9, 78%), pyrexia (6/9, 78%), peripheral lymphadenopathy (6/9) and weight loss (5/9). Frequently affected lymph nodes were submandibular (5/9), popliteal (4/9) and jejunal (4/9). Cytology was more commonly neutrophilic (8/14, 57%) than pyogranulomatous (4/14, 29%). After variable infectious disease testing, all cats received prednisolone (median dose 1.25 mg/kg, range 0.5–2.3 mg/kg) for a median of 5.75 months (range 4–11 months). All improved initially; relapse occurred in 33% during treatment, following tapering or discontinuation. Two cats (22%) were euthanised after relapse; one developed neurological signs. Conclusions and relevance: Steroid-responsive lymphadenitis should be considered in cats presenting with inflammatory lymphadenopathy when no identifiable underlying infectious, inflammatory or neoplastic cause is identified, and most cases respond well to glucocorticoid treatment.
No takes yet. Share an insight, caveat, or question.
Doyle et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: